The new allosteric inhibitor asciminib is susceptible to resistance mediated by ABCB1 and ABCG2 overexpression <i>in vitro</i>
Laura N Eadie(South Australian Health and Medical Research Institute), Timothy P. Hughes(South Australia Pathology)
Cited by 59
Related Papers
No related papers found
Powered by citation graph analysis